neurofibromatosis (central) type 2
Jump to navigation
Jump to search
Epidemiology
- the most common such syndrome with multiple schwannomas
Pathology
- bilateral acoustic neuromas (vestibular schwannomas)
- schwannomas of other cranial & peripheral nerves, meningiomas, & ependymomas
- dermal (peripheral nerve) schwannomas may precede vestibular tumors in affected children
- few neurofibromas
- no Lisch nodules
- tumors are histologically benign; however, their anatomic location makes management difficult, & patients suffer great morbidity & mortality
Genetics
- chromosome 22q12 mutation
- autosomal dominant with full penetrance
- associated with defects in NF2
Clinical manifestations
- affected individuals generally develop symptoms of cranial nerve 8 dysfunction in early adulthood, including deafness & balance disorder
- gradually progressive bilateral hearing loss, tinnitus
- visual changes, bilateral cataracts
- peripheral neuropathy
- few cafe-au-lait spots
Laboratory
Radiology
- MRI evidence of bilateral vestibular schwannomas
More general terms
Additional terms
- merlin; moesin-ezrin-radixin-like protein; neurofibromin-2; schwannomin; schwannomerlin (NF2, SCH)
- neurofibromatosis-2 genotyping
- schwannomatosis (congenital cutaneous neurilemmomatosis)
References
- ↑ Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 175
- ↑ UniProt http://www.uniprot.org/uniprot/P35240.html
- ↑ Medical Knowledge Self Assessment Program (MKSAP) 20 American College of Physicians, Philadelphia 2025
- ↑ Coy S, Rashid R, Stemmer-Rachamimov A, et al. An update on the CNS manifestations of neurofibromatosis type 2. Acta Neuropathol. 2020;139:643-665. PMID: https://pubmed.ncbi.nlm.nih.gov/31161239
Patient information
neurofibromatosis type-2 patient information